Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
38 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Microbot Medical Inc.’s names, not what it holds today.
Patents granted
38
38 utility, 1976 to Dec 31, 2025
Granted in 2025
none
in the last year the record reads
Applications published
0
since 2001, to Dec 31, 2025
Names they are printed under
2
a former name
By yearGrantedApplications published
'96'97'98'99'00'01'02'07'10'12
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
Under which name2 counted
Cytotherapeutics, Inc. a former name
US, as the owner printed on each patent
0 publishedStemCells, Inc. a former name
US, as the owner printed on each patent
0 publishedNames not counted (2)
Microbot Medical Inc.
Most of its patents print IL; this name counts in US. 7 granted and 13 published under it are not counted.
Microbot Medical Inc.
Most of its patents print IL; this name counts in US. 0 granted and 16 published under it are not counted.
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|
| Oct 9, 2012 | 8,283,164 | Liver engrafting cells, assays, and uses thereof | Pharmaceuticals | StemCells, Inc. |
| Oct 12, 2010 | 7,811,818 | Human liver engrafting cells isolated from adult liver tissue | Pharmaceuticals | StemCells, Inc. |
| May 1, 2007 | 7,211,404 | Liver engrafting cells, assays, and uses thereof | Pharmaceuticals | StemCells, Inc. |
| Dec 24, 2002 | 6,498,018 | Cultures of human CNS neural stem cells | Pharmaceuticals | Cytotherapeutics, Inc. |
| Oct 22, 2002 | 6,468,794 | Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations | Pharmaceuticals | StemCells, Inc. |
| Jun 18, 2002 | 6,407,204 | Use of conantokins for producing analgesia or for neuoprotection | Pharmaceuticals | Cytotherapeutics, Inc. |
| May 29, 2001 | 6,238,922 | Use of collagenase in the preparation of neural stem cell cultures | Biotechnology | StemCells, Inc. |
| Aug 15, 2000 | 6,103,530 | Cultures of human CNS neural stem cells | Pharmaceuticals | Cytotherapeutics, Inc. |
| Apr 25, 2000 | 6,054,142 | Biocompatible devices with foam scaffolds | Pharmaceuticals | Cytotherapeutics, Inc. |
| Feb 22, 2000 | 6,027,721 | Device and method for encapsulated gene therapy | Pharmaceuticals | Cytotherapeutics, Inc. |
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.